UA98845U - Pharmaceutical composition comprising co-crystal of choline epalrestat - Google Patents

Pharmaceutical composition comprising co-crystal of choline epalrestat

Info

Publication number
UA98845U
UA98845U UAU201412435U UAU201412435U UA98845U UA 98845 U UA98845 U UA 98845U UA U201412435 U UAU201412435 U UA U201412435U UA U201412435 U UAU201412435 U UA U201412435U UA 98845 U UA98845 U UA 98845U
Authority
UA
Ukraine
Prior art keywords
pharmaceutical composition
epalrestat
choline
crystal
thioco
Prior art date
Application number
UAU201412435U
Other languages
Russian (ru)
Inventor
Isabel Kalofonos
G Patric Stahly
William Martin-Doyle
Dimitris Kalofonos
Jeffrey Stults
Travis L Houston
Original Assignee
Bionevia Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bionevia Pharmaceuticals Inc filed Critical Bionevia Pharmaceuticals Inc
Priority to UAU201412435U priority Critical patent/UA98845U/en
Publication of UA98845U publication Critical patent/UA98845U/en

Links

Abstract

Фармацевтична композиція включає холін водневий двокислотний співкристал 5-[(1Z,2E)-2-мeтил-3-фeнілпpoпeнілiдeн]-4-oкco-2-тіокco-3-тiaзoлiдинoцтoвoої кислоти.The pharmaceutical composition comprises choline hydrogen bicarbonate 5 - [(1Z, 2E) -2-methyl-3-phenylpropenylidene] -4-oxo-2-thioco-3-thiazolidine acid.

UAU201412435U 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat UA98845U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201412435U UA98845U (en) 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201412435U UA98845U (en) 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat

Publications (1)

Publication Number Publication Date
UA98845U true UA98845U (en) 2015-05-12

Family

ID=53674710

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201412435U UA98845U (en) 2014-11-19 2014-11-19 Pharmaceutical composition comprising co-crystal of choline epalrestat

Country Status (1)

Country Link
UA (1) UA98845U (en)

Similar Documents

Publication Publication Date Title
DK3277677T3 (en) 1-cyano-pyrrolidine compounds as usp30 inhibitors
HRP20220075T1 (en) A liquid formulation comprising nicotine for aerosol administration
BR112016023628A2 (en) pharmaceutical compositions.
DK3236943T3 (en) COMPOSITIONS FOR ILEO-JEJUNAL DRUG ADMINISTRATION
DK3325487T3 (en) FORMULATION FOR SOFT, ANTICHOLINERGE ANALOGS
DK3297605T3 (en) TOPIC, PHARMACEUTICAL COMPOSITIONS
DK3229810T3 (en) PHOSPHOLIPID-ETHER ANALOGES AS CANCER-DISABLING MEDICINES
BR112016021012A2 (en) pharmaceutical compositions of therapeutically active compounds.
DK3332767T3 (en) Liquid inhalation formulation comprising RPL554
DK3235819T3 (en) Pyrrolopyrimidine compounds useful as JAK inhibitors
CL2014003447S1 (en) Fridge.
BR112017013156A2 (en) active compound combinations.
DK3232780T3 (en) Aqueous adjuvant compositions containing electrolyte, compositions containing an active substance and their use
BR112017012801A2 (en) active compound combinations.
BR112016026143A2 (en) methods and compositions comprising 10-hydroxy-2-decenoic acid.
DK3394045T3 (en) CO-CRYSTAL, MANUFACTURING PROCEDURE AND MEDICINE CONTAINING CO-CRYSTAL.
EP3153156A4 (en) Composition based on a stabilized solution of active ingredients
DK3204380T3 (en) HIS UNKNOWN AMINOPYRIDINE COMPOUNDS USED AS INHIBITORS OF PROTEIN PRENYLING
BR112016018071A2 (en) Larvicide composition.
FR3025096B1 (en) GEL / GEL COMPOSITION CONTAINING ANTI-TRANSPARENT ACTIVE INGREDIENT
CL2016002704A1 (en) Stable compositions of neuroactive peptides.
DK2915526T3 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING ANAGRELID
FR3022292B1 (en) THERMALLY CONTROLLED TUBULAR STIFFENER
UA98845U (en) Pharmaceutical composition comprising co-crystal of choline epalrestat
CL2016003220A1 (en) Intravaginal formulations comprising gnrh.